Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayla Fourzali

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Safety|February 18, 2020
Safety considerations when using drugs to treat pruritusKayla Fourzali, Gil Yosipovitch
Dermatitis : Contact, Atopic, Occupational, Drug|November 18, 2022
An Approach to Hypereosinophilic Syndrome Presenting With Cutaneous FeaturesKayla Fourzali, Gil Yosipovitch, Andrea Maderal
Immunotherapy|September 7, 2020
Dupilumab use in atopic dermatitis and beyond in skin diseasesKayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch
Expert Opinion on Emerging Drugs|July 28, 2020
Emerging drugs for the treatment of chronic pruritic diseasesKayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch
The Journal of Investigative Dermatology|December 21, 2020
Cutaneous Gene Expression in Primates with ItchLeigh A Nattkemper, Kayla Fourzali, Gil Yosipovitch
Pediatric Dermatology|January 29, 2026
Improving Clinical Photography for All Skin Types: The Role of a Mobile Gray BackdropSarah A Commaroto, Kayla Fourzali, Christina Gundersen, et al.
JAAD Case Reports|May 29, 2026
A rare case of PAPASH syndrome with a NOD2 mutationYaelle Shaked, Anika Pulumati, Alison H Kucharik, et al.
Cureus|December 8, 2025
Mapping Online Discourse on Topical Steroid Withdrawal: Accuracy, Safety, and Supporting EvidenceJoyce J Zhu, Annabel Hou, Jillian Baader, et al.
Acta Dermato-Venereologica|July 30, 2020
The Pleasurability of Scratching an Itch Amongst Different Pruritic ConditionsRachel Shireen Golpanian, Kayla Fourzali, Emilie Fowler, et al.
Acta Dermato-Venereologica|April 22, 2020
Psychiatric Comorbidities in Non-psychogenic Chronic Itch, a US-based StudyRachel Shireen Golpanian, Zoe Lipman, Kayla Fourzali, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Safety|February 18, 2020
Safety considerations when using drugs to treat pruritusKayla Fourzali, Gil Yosipovitch
Dermatitis : Contact, Atopic, Occupational, Drug|November 18, 2022
An Approach to Hypereosinophilic Syndrome Presenting With Cutaneous FeaturesKayla Fourzali, Gil Yosipovitch, Andrea Maderal
Immunotherapy|September 7, 2020
Dupilumab use in atopic dermatitis and beyond in skin diseasesKayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch
Expert Opinion on Emerging Drugs|July 28, 2020
Emerging drugs for the treatment of chronic pruritic diseasesKayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch
The Journal of Investigative Dermatology|December 21, 2020
Cutaneous Gene Expression in Primates with ItchLeigh A Nattkemper, Kayla Fourzali, Gil Yosipovitch
Pediatric Dermatology|January 29, 2026
Improving Clinical Photography for All Skin Types: The Role of a Mobile Gray BackdropSarah A Commaroto, Kayla Fourzali, Christina Gundersen, et al.
JAAD Case Reports|May 29, 2026
A rare case of PAPASH syndrome with a NOD2 mutationYaelle Shaked, Anika Pulumati, Alison H Kucharik, et al.
Cureus|December 8, 2025
Mapping Online Discourse on Topical Steroid Withdrawal: Accuracy, Safety, and Supporting EvidenceJoyce J Zhu, Annabel Hou, Jillian Baader, et al.
Acta Dermato-Venereologica|July 30, 2020
The Pleasurability of Scratching an Itch Amongst Different Pruritic ConditionsRachel Shireen Golpanian, Kayla Fourzali, Emilie Fowler, et al.
Acta Dermato-Venereologica|April 22, 2020
Psychiatric Comorbidities in Non-psychogenic Chronic Itch, a US-based StudyRachel Shireen Golpanian, Zoe Lipman, Kayla Fourzali, et al.
Pageof 2